A two-gene epigenetic signature for the prediction of response to neoadjuvant chemotherapy in triple-negative breast cancer patients

Overview of attention for article published in Clinical Epigenetics, February 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

So far, Dimensions has found 41 publications that cite this research output.

Book chapter (February 2024)

Article in Journal of Translational Medicine (November 2023)

Article in Experimental and Molecular Pathology (September 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.